medline.ch Gynäkologie Mammae

	Medicaid Expansion and Overall Mortality in Lung, Breast, and Colorectal Cancer: A Difference-in-Differences Study. Am Surg Akinyemi O, Heath JB, Oyebanji O, Fasokun M, Akinwumi B, Nnorom S, Ogunyankin F, Hughes K, Cornwell E 3rd, Levy G. PMID: 42640027 [PubMed - as supplied by publisher]
	Assessment of Potentially Unnecessary Breast Magnetic Resonance Imaging Utilization and Its Economic Impact: A Retrospective Study. Eurasian J Med , K, Kantarc, Ayd. PMID: 42639798 [PubMed]
	Breast Cancer Knowledge, Awareness and Screening Practices Among Female Healthcare Workers in Al-Mukalla, Yemen. Sultan Qaboos Univ Med J Al Shoaeeb W, Badheeb AM, Ahmed F, Bawazir A, Nabhan AB, Badheeb M, Bayazid A. PMID: 42639501 [PubMed - indexed for MEDLINE]
	Skeletal Muscle Mass in Women With Breast Cancer: Evaluation of Agreement Between Different Methods. J Nutr Metab Souza JAN, Dos Santos DM, da Silva LBL, Garcia MRPDS, Rechinelli AB, Machado JM, Albergaria BH, Bernabé RAM, Marques-Rocha JL, Guandalini VR. PMID: 42639370 [PubMed]
	Biomarker-driven neoadjuvant immunotherapy in triple-negative breast cancer: emerging therapeutic targets FOXP3 and WT1. Front Immunol Zhang Z, Zhao R, Hu Y, Xie Q, Yu Y, Li K, Ding Z, Wang M. PMID: 42638924 [PubMed - indexed for MEDLINE]
	Second Breast-Conserving Treatment for Ipsilateral Breast Tumor Recurrence: A Review of Patient Selection, Reirradiation Techniques, and Clinical Outcomes. Int J Cancer Cheptea C, Kirova Y, Mitrica RI, Badea M, Loap P. PMID: 42638516 [PubMed - as supplied by publisher]
	Microwave Ablation for Granulomatous Lobular Mastitis: A Narrative Review. Med Sci Monit Yao H, Li L, Yin J, Li W, Saiding A. PMID: 42638288 [PubMed - indexed for MEDLINE]
	AI-based multimodal fusion for preoperative prediction of breast microcalcifications: combining mammography and tomosynthesis. BMC Med Imaging Wei J, Li J, Pan R, Cao M, Ma C, Xie Z, Ma Y, Gao Z. PMID: 42638095 [PubMed - indexed for MEDLINE]
	Interventional Radiology in the Management of Breast Cancer: Current Role and Future Directions. Cardiovasc Intervent Radiol Plastira C, Panourgias E, Chatziioannou A, Krokidis M. PMID: 42637827 [PubMed - as supplied by publisher]
	Metaplastic breast cancer: A single-centre retrospective experience. Surgeon Siddiky S, Nayeem SR, McLean NR, Youssef M, Humphreys A. PMID: 42637650 [PubMed - as supplied by publisher]
	The Association of 5-Î± Reductase Inhibitors for Benign Prostatic Hyperplasia with Development of Male Breast Disease and Erectile Dysfunction: A Retrospective Cohort Study of TriNetX Database. Urology Titus RS, Bhatia A, Lozano VE, Khandekar A, Shah HN. PMID: 42637099 [PubMed - as supplied by publisher]
	Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial. Ann Oncol Garber JE, Cameron D, Campbell C, Yothers G, Taboada M, El-Abed S, Rastogi P, McConnell R, Correa A, Delaloge S, Liu WT, Sharma P, Bergh J, Janni W, Balmaña J, Loman N, , Friedman S, Freeman T, Armstrong A, Korde L, Im S, Sagara Y, Viale G, Bliss J, Gianni L, Jóhannsson Ó, Zoppoli G, De Dueñas EM, Marmé F, Fein L, Arnedos M, Ford J, Schmutzler R, Loibl S, Linderholm B, Lakhani SR, Gnant M, Gelmon K, Domchek SM, Senkus E, Eisen A, Jager A, Piccart M, Phillips KA, Traina T, Stickeler E, Singer CF, Shao Z, Liu X, Tipping H, Aktan G, Martinez M, Canon JL, Takahashi M, Yasojima H, Middleton K, Pristauz-Telsnigg G, Pfeiler G, Virani S, Valdes-Albini F, Wolmark N, Mesa ID, Paterson V, Gelber RD, Geyer CE Jr, Tutt ANJ. PMID: 42636977 [PubMed - as supplied by publisher]
	Triangulating evidence to evaluate selection bias in lifecourse Mendelian randomization studies: a practical framework illustrated by early-life adiposity and breast cancer. J Clin Epidemiol Power GM, Sanderson E, Gkatzionis A, Richardson TG, Tilling K, Smith GD, Hemani G. PMID: 42636914 [PubMed - as supplied by publisher]
	Efficacy of immediate lymphatic reconstruction after breast cancer surgery: A systematic review and time-course dynamics meta-analysis. J Reconstr Microsurg Chang HJ, Chen KY, Chiu WK, Hoang KD, Pai TW, Sun CY, Chen C. PMID: 42636877 [PubMed - as supplied by publisher]
	Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group. Lancet Oncol Gunster JLB, Tramm T, Machiels M, Demaria S, Formenti SC, de Caluwe A, Duane F, Klein J, Sur D, Somaiah N, Rakovitch E, Jerzak KJ, Lu FI, Hiley CT, Brackstone M, Ehinger A, Maley SK, Acs B, Zerdes I, Ozcan D, Khramtsov A, Salido E, Papathomas TG, Sharma P, Stecklein S, Khramtsova G, Horvath Z, Markov D, Hardas A, do Prado Moura JF, Ramirez A, Woodward WA, Sivapiragasam A, Denkert C, Michiels S, Loi S, Poortmans P, Mutter RW, Salgado R, Tran WT, International Immuno-Oncology Biomarker Working Group. PMID: 42636842 [PubMed - indexed for MEDLINE]
	Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study. Lancet Oncol Dixon-Douglas JR, Drubay D, Salgado R, Acs B, van der Laak J, Yuan Y, Amgad M, Cooper L, Hagos Y, AbdulJabbar K, Meakin J, van Ginneken B, Yan H, Lemonnier J, Penault-Llorca F, Lacroix-Triki M, Joensuu H, Kellokumpu-Lehtinen PL, Loibl S, Denkert C, Viale G, Colleoni MA, Sotiriou C, Piccart M, Dieci MV, Demaria S, Kammler R, Wolff AC, Sparano JA, Adams S, Badve S, Gray RJ, Curigliano G, Salomon AV, Nielsen TO, Pusztai L, Ciompi F, Michiels S, Loi S, International Immuno-Oncology Biomarker Working Group. PMID: 42636839 [PubMed - indexed for MEDLINE]
	Manual, digital, and AI tumour-infiltrating lymphocyte scoring: a secondary analysis of the APHINITY randomised trial. Lancet Oncol Lara González LE, Giudici F, Salgado R, Yan H, Rojo F, Comerma L, Wienert S, Palacios J, Kos Z, de Haas SL, Rodriguez-Lescure A, Viale G, Zheng Y, Gao D, Kiermaier A, Andre F, Loibl S, Piccart MJ, Gelber R, Cameron D, Krop IE, Savas P, Nielsen TO, Denkert C, Michiels S, Loi S, APHINITY Steering Committee and Investigators and The International Immuno-Oncology Biomarker Working Group. PMID: 42636838 [PubMed - indexed for MEDLINE]
	Solid papillary carcinoma of the breast: A clinicopathological study with emphasis on unusual immunohistochemical and genetic features. Pathol Res Pract Hu B, Wang T, Yu J, Yan W. PMID: 42636673 [PubMed - as supplied by publisher]
	Based on Raman spectroscopy and clinical laboratory tests: Developing a fusion model to predict neoadjuvant therapy response in breast cancer. Transl Oncol Chen X, Li Z, Li Y, Chen Z, Song J, Wu H, Liu S, Li L, Li J. PMID: 42636655 [PubMed - as supplied by publisher]
	Ultrasound localisation microscopy predicts neoadjuvant chemotherapy response in patients with breast cancer. EBioMedicine Porte C, Kohlen M, Lisson T, Dencks S, von Stillfried S, Magnuska ZA, Winkler BS, Rix A, Koczera P, Boor P, Talbot SR, Schmitz G, Stickeler E, Kiessling F. PMID: 42636598 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 221387

Seite 1 von 11070

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung